• For Supporters

"If my energy ever flags, Mick’s there as living proof": Jill May on raising a million for cancer research

How an incurable lung cancer diagnosis compelled one City banker to swap the trading floor for fundraising events that have raised over £1m towards our work. How an incurable lung cancer diagnosis compelled one City banker to swap the trading floor for fundraising events that have raised over £1m towards our work.

17 October 2019

• For Researchers

Carving out a research niche in early detection: Charlie Massie, Career Development Fellow

Charlie explains how he demonstrated the skills and experience we expect of a Career Development Fellow. Charlie explains how he demonstrated the skills and experience we expect of a Career Development Fellow.

17 October 2019

• Health & Medicine

Improving cancer screening: what does the latest review recommend?

What do the latest recommendations from Sir Mike Richards mean for screening in England? We take a look. What do the latest recommendations from Sir Mike Richards mean for screening in England? We take a look.

16 October 2019

• Personal Stories

Defiant men and women stand up to cancer and bare their scars in raw photo series

Sixteen men and women who have been diagnosed with cancer have taken part in a photoshoot for Stand Up To Cancer, giving an unfiltered look at the disease. Sixteen men and women who have been diagnosed with cancer have taken part in a photoshoot for Stand Up To Cancer, giving an unfiltered look at the disease.

14 October 2019

• Science & Technology
• Health & Medicine

News digest –  Dame Sally Davies, lung cancer predictions, fast food packaging and CRISPR

Taking blood during surgery could help scientists decide how likely lung cancer is to return after surgery. Taking blood during surgery could help scientists decide how likely lung cancer is to return after surgery.

12 October 2019

• Health & Medicine

Womb cancer stats reveal treatment variation across England

Our new stats show a staggering variation in treatment plans for women diagnosed with womb cancer across England. Our new stats show a staggering variation in treatment plans for women diagnosed with womb cancer across England.

11 October 2019

• Health & Medicine

Advanced ovarian cancer treatment approved for Cancer Drugs Fund

A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund. A targeted treatment for advanced ovarian cancer has been approved for use on the NHS in England and will be paid for by the Cancer Drugs Fund.

11 October 2019

• Health & Medicine

New batch of treatment decisions for NHS Scotland

The Scottish Medicines Consortium (SMC) has made decisions on five new cancer treatments, including a personalised blood cancer immunotherapy. The Scottish Medicines Consortium (SMC) has made decisions on five new cancer treatments, including a personalised blood cancer immunotherapy.

10 October 2019

• For Supporters

5 key takeaways from our review of the financial year

From income to insight, we pick out some of the important themes from this year’s Annual Report & Accounts. From income to insight, we pick out some of the important themes from this year’s Annual Report & Accounts.

10 October 2019

• Science & Technology

Predicting lung cancer’s return at surgery

New lung cancer research shows that detecting potential tumour cells leaving the vein in the lung at surgery may predict the diseases return. New lung cancer research shows that detecting potential tumour cells leaving the vein in the lung at surgery may predict the diseases return.

7 October 2019

• Health & Medicine

Secrets of lung cancer spread found in patients' blood and biopsies

Three studies from Cancer Research UK's TRACERx project reveal early signs that lung cancer may spread and become untreatable. Three studies from Cancer Research UK's TRACERx project reveal early signs that lung cancer may spread and become untreatable.

7 October 2019

• For Researchers

Walking the path to leadership in cancer immunotherapy: Dr Sean Lim, Advanced Clinician Scientist Fellow

Dr Sean Lim tells us about her successful progression from Clinician Scientist Fellow to Advanced Clinician Scientist Fellow. Dr Sean Lim tells us about her successful progression from Clinician Scientist Fellow to Advanced Clinician Scientist Fellow.

7 October 2019